Publication | Closed Access
The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression
16
Citations
47
References
2020
Year
HepatologyHuman Hepatocellular CarcinomaMedicineLiver PhysiologyPathologyCarbonyl Reductase 1Liver CancerAnti-cancer AgentPharmacologyHepatocellular CarcinomaCancer ResearchOxidative Stress
| Year | Citations | |
|---|---|---|
Page 1
Page 1